Choosing an ibogaine clinic is one of the most consequential decisions in a treatment journey. Because ibogaine carries real cardiac and neurological risks, the quality of medical oversight, screening protocols, and aftercare support varies dramatically between providers — and those differences can be life-or-death. This guide covers the key criteria researchers and prospective patients use to evaluate clinics operating in legal jurisdictions.

Safety notice: Ibogaine is a Schedule I controlled substance in the United States, making its administration illegal outside approved research contexts. Clinics legally offering ibogaine operate in countries such as Mexico, Canada, Portugal, the Netherlands, and others. Cardiac-related deaths have been documented in association with ibogaine use; rigorous pre-treatment medical screening is essential. Never administer ibogaine outside a supervised medical setting.

Why Does Clinic Quality Matter So Much With Ibogaine?

Ibogaine is not a typical wellness supplement. It is a potent psychoactive alkaloid derived from the Tabernanthe iboga shrub that produces profound neurological effects lasting 18–36 hours. Research published in Molecules (Koenig & Hilber, 2015) identified ibogaine's ability to block hERG potassium channels in the heart, which can prolong the QT interval and, in vulnerable individuals, precipitate potentially fatal arrhythmias. A retrospective review of ibogaine-related fatalities (Litjens & Brunt, 2016) found that many deaths were associated with pre-existing cardiac conditions, polydrug use, or inadequate medical monitoring.

High-quality clinics screen for these risks before dosing. Lower-quality operations may not — which is why knowing what to look for is essential before committing to any provider.

What Medical Screening Should a Reputable Clinic Require?

A credible clinic will require comprehensive pre-treatment screening well before you arrive. This is not optional paperwork; it is the primary safety mechanism. Look for clinics that mandate all of the following:

  • 12-lead electrocardiogram (ECG/EKG): Used to rule out prolonged QTc interval, Brugada syndrome, and other arrhythmia risk factors. This is the single most critical test.
  • Complete blood panel: Liver function tests (ibogaine is hepatically metabolized), kidney function, complete blood count, and electrolyte levels.
  • Comprehensive medication and substance history: Many medications — including methadone, certain antidepressants, and antifungals — are contraindicated with ibogaine due to QT prolongation or dangerous drug interactions.
  • Psychological evaluation: Screening for psychosis, severe bipolar disorder, or other contraindicated psychiatric conditions.
  • Current drug use assessment: Particularly important for opioid users; the timing of last use affects both safety and protocol design.

The Global Ibogaine Therapy Alliance's 2015 clinical guidelines recommend that screening be reviewed by a licensed physician, not just administrative staff. Ask the clinic explicitly who reviews your intake materials and what their credentials are.

What Staff Credentials and Medical Infrastructure Should Be in Place?

Staffing and on-site infrastructure directly determine how a clinic can respond if something goes wrong during a session. When evaluating a clinic, ask the following questions directly:

  • Is a licensed medical doctor (MD or equivalent) present on-site during all ibogaine sessions — not simply on-call?
  • Is continuous cardiac monitoring (pulse oximetry and ECG) conducted throughout the acute experience?
  • What resuscitation equipment is available on-site? Is there a defibrillator?
  • What is the staff-to-patient ratio during active sessions? Reputable clinics typically maintain a low ratio, often 1:1 or 1:2 during the acute phase.
  • What is the protocol if a patient requires emergency medical transfer? How far is the nearest hospital?

Clinics that cannot or will not answer these questions clearly should be treated with serious skepticism. Transparency about safety infrastructure is a baseline expectation, not a premium feature.

How Should You Evaluate a Clinic's Treatment Protocol and Philosophy?

Ibogaine is not a single-session cure. Research, including a 12-month follow-up study by Noller et al. (2018) published in the American Journal of Drug and Alcohol Abuse, suggests that outcomes are substantially improved when ibogaine is embedded in a broader therapeutic framework. Evaluate a clinic's protocol on these dimensions:

  • Preparation: Does the clinic provide structured psychological preparation before the session? This typically includes goal-setting, intention work, and education about what to expect.
  • Dosing approach: Reputable clinics use individualized dosing based on body weight and health status, not one-size-fits-all protocols. Some use a test dose before a full flood dose.
  • Integration support: What happens after the acute experience? A clinic that sends patients home with no follow-up plan is not offering comprehensive care. Look for structured integration sessions — in person, by video, or through a referral network — in the weeks following treatment.
  • Length of stay: Reputable medical detox programs often recommend a minimum stay of several days post-dosing for medical observation and stabilization before discharge.

What Are the Red Flags That Signal a Clinic to Avoid?

Not every provider offering ibogaine operates to the same standard. The following are concrete warning signs:

  • No mandatory pre-treatment ECG. This is a non-negotiable safety requirement. Any clinic that does not require one should be avoided entirely.
  • Guarantees of success. No reputable provider guarantees addiction remission. Ibogaine is a tool, not a cure, and outcomes vary.
  • Pressure to book quickly. High-pressure sales tactics are inconsistent with patient-centered medical care.
  • Inability to provide staff credentials. Legitimate clinics can name their medical director and provide verifiable licensing information.
  • No written informed consent process. Proper informed consent is a cornerstone of ethical medical practice.
  • Unusually low pricing. Quality medical infrastructure, trained staff, and monitoring equipment have real costs. Extremely low prices can reflect corners being cut on safety.
  • No aftercare or integration plan whatsoever. Schenberg et al. (2014) noted that without psychosocial support post-treatment, relapse rates increase substantially.

How Do You Verify a Clinic's Track Record and Legitimacy?

Independent verification is difficult but not impossible. Consider these approaches:

  • Request references. Ask the clinic for contact information for former patients willing to speak about their experience. Established clinics should be able to facilitate this.
  • Check community forums. Peer-reviewed information is sparse, but communities of ibogaine treatment alumni exist online and can offer candid first-person accounts. Treat these as one data point among many, not definitive evidence.
  • Ask about membership in professional bodies. Organizations such as the Global Ibogaine Therapy Alliance (GITA) have published clinical guidelines and some member clinics voluntarily adhere to them.
  • Consult an independent addiction medicine physician. An addiction specialist in your home country can review a clinic's screening protocol and give you an objective assessment before you commit.
  • Verify the legal status in the clinic's country. Ibogaine's legal status varies by jurisdiction. Confirm independently — not just through the clinic — that the treatment is legally permissible where you plan to travel.

Frequently Asked Questions

Ibogaine is Schedule I in the United States, meaning it cannot be legally administered there outside of an approved FDA investigational setting. However, it is legal or unscheduled in several countries including Mexico, Portugal, the Netherlands, and others. Clinics operating in those jurisdictions are functioning within their local laws. Always verify legal status independently for both the country where treatment occurs and your home country's import/export rules.
Costs currently range widely — roughly $3,000 to $15,000 USD or more depending on the country, duration of stay, level of medical oversight, and amenities offered. Be cautious of prices at either extreme. Very low prices may signal inadequate medical infrastructure; very high prices do not automatically guarantee quality. Always ask for an itemized breakdown of what is included.
Methadone in particular presents significant interaction risks with ibogaine, including additive QT prolongation. Most reputable clinics require patients to transition off methadone for a period before treatment — sometimes several weeks — and some will not accept active methadone patients at all. Buprenorphine protocols vary by clinic. This must be discussed in detail during intake, and any tapering plan should be supervised by a physician.
The acute ibogaine experience typically lasts 18–36 hours. However, most reputable programs recommend a minimum stay of 5–10 days total to allow for pre-treatment preparation, the acute session, medical monitoring during recovery, and initial integration work. Programs focused on detoxification may differ in length from those focused on psychospiritual exploration. Ask for a day-by-day program schedule before booking.
Integration refers to the psychological work of making meaning from the ibogaine experience and translating insights into sustainable behavioral change. Research including the Noller et al. (2018) follow-up study suggests that outcomes improve when pharmacological treatment is paired with ongoing psychosocial support. A good clinic will either provide integration sessions directly or connect you with a qualified therapist familiar with psychedelic experiences before you return home.
Yes. Absolute contraindications identified in clinical literature include significant cardiac conditions (especially prolonged QTc interval, Brugada syndrome, or a history of arrhythmia), severe liver disease, active psychosis, and use of medications that interact with ibogaine's cardiac or metabolic pathways. Pregnancy is also a contraindication. A thorough medical evaluation by a licensed physician is required to identify individual risk factors.
Yes, and this is strongly advisable. Your home physician can review your cardiac and medication history with ibogaine-specific risks in mind, flag contraindications, and help you obtain necessary pre-screening tests. They can also coordinate care upon your return. Some physicians may be unfamiliar with ibogaine specifically; if so, consulting an addiction medicine specialist who has experience with psychedelic-assisted approaches may be helpful.

Selecting an ibogaine clinic deserves the same rigor you would apply to any serious medical decision. Speak with an addiction medicine physician and, if possible, a mental health professional before committing to any program. Use the criteria above as a structured framework during your conversations with clinics, and do not allow urgency, financial pressure, or hope alone to substitute for thorough due diligence. The right clinic will welcome your questions — and answer them clearly.

Informational only. Not medical or legal advice. Ibogaine is Schedule I in the US. Consult qualified professionals.